KSL-128114 TFA
KSL-128114 is a syntenin inhibitor (Ki = 300 nM) that reduces viability of melanoma and glioblastoma cells in vitro. In a GBM PDX model, intracranial implantation of pre-treated cells extended mouse survival, supporting its research use in oncology and neurobiology studies.
Product Specifications
Field of Research
Immunology & Inflammation
Molecular Weight
2201.60
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
